reference/17409733

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17409733

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	2076
issn	0006-4971 1528-0020
issueIdentifier	8
pageRange	2069-2076
publicationName	Blood
startingPage	2069
bibliographicCitation	Guglielmelli P, Barosi G, Rambaldi A, Marchioli R, Masciulli A, Tozzi L, Biamonte F, Bartalucci N, Gattoni E, Lupo ML, Finazzi G, Pancrazzi A, Antonioli E, Susini MC, Pieri L, Malevolti E, Usala E, Occhini U, Grossi A, Caglio S, Paratore S, Bosi A, Barbui T, Vannucchi AM; AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM) investigators. Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis. Blood. 2011 Aug 25;118(8):2069–76. PMID: 21725052; PMCID: PMC3365876.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_625db4668daa07bf4ae67e2e55b636a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_894b1d1dd001b00c59dc710403c81ee2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5486-4838 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8e58033b8d4f540994cb850322752d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cb5a119497387138272214220c53d34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c236dd1e3c3f12360711e94b91f7bfd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffe64f8844f7dff27bd9f4cc1f3c4938 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bfd61f84f8c89f1f560e314278580c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc54c76bd0fbecb5ae57f9afbe91a70c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79947e4c8fa59c12ae18fe300560e11d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b77602fdd3047bde6ce4067d30a36e33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1812-8072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c4de846100060dc3c8be5743fa352e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b574317c09893c7d64fde70b4676c5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61762c9e90e7d1d99b8eed209e468bdc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2aa6a60eaf974c82ae15493503e085b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1809-284X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71609cd607d0096fc0a03d94918f0d0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3248-3863 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6943-6924 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fb60a818b99c3cdf7c2f12e568bfece http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92b8dd89bafba584271f995186900868 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9328-3948 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00aff310e58a1b933617dba6065b404f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12979b6a46f5a65628cc2188d37328b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49643e409ac52f07e9dbbfa5771efad9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0679-5030 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13ea39dca8182d85b9225217e768af5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44193ca05e7e17322491eb07185e487d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_806e7191474ed1ed209f556203c8c12d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6afb0219d400a8379594440c6d9bec8
date	2011-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21725052 https://pubmed.ncbi.nlm.nih.gov/PMC3365876 https://doi.org/10.1182/blood-2011-01-330563
isPartOf	https://portal.issn.org/resource/ISSN/1528-0020 https://portal.issn.org/resource/ISSN/0006-4971 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
discusses	http://id.nlm.nih.gov/mesh/M0473784 http://id.nlm.nih.gov/mesh/M0469193 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0219125 http://id.nlm.nih.gov/mesh/M0193890 http://id.nlm.nih.gov/mesh/M0495063 http://id.nlm.nih.gov/mesh/M0029612 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0203030 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0502630 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0019167
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055728Q000188 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D058570Q000037 http://id.nlm.nih.gov/mesh/D020123Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000068338 http://id.nlm.nih.gov/mesh/D013920Q000150 http://id.nlm.nih.gov/mesh/D055728Q000201 http://id.nlm.nih.gov/mesh/D055728Q000209 http://id.nlm.nih.gov/mesh/D020123Q000009 http://id.nlm.nih.gov/mesh/D047428Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D053628Q000235 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012333Q000378 http://id.nlm.nih.gov/mesh/D012333Q000235 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D053614Q000235 http://id.nlm.nih.gov/mesh/D019938Q000235 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011087Q000150 http://id.nlm.nih.gov/mesh/D025721Q000235 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D020123Q000627 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8315 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9409 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11133 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7171dd85da4bc71fb6b3ed6fce16d9f1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9285 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128132375 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214

Total number of triples: 111.